Dr. Escorcia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1275 York Avenue
New York, NY 10065Phone+1 212-639-2000
Summary
- I am a board-certified radiation oncologist and scientist committed to improving the quantity and quality lives of people with cancer.
Clinically, I treat patients with cancers amenable to radiotherapy, with particular interest in cancers of the gut, including liver and pancreas cancers.
For my research, I leverage my expertise in bioengineering, chemistry, pharmacology, and oncology to design, engineer, and test of novel tumor-selective imaging and therapeutic agents for human cancers in general, and liver cancers in particular, with translational intent.
I have brought together motivated trainees, and scientists to form the Laboratory of Molecular Radiotherapy within the Molecular Imaging Branch at the National Cancer Institute, with goals to
1) identify tumor selective targets,
2) discover novel biomolecules specific to targets of interest,
3) design, engineer, and test novel radioconjugates from these biomolecules using in vitro assays and in vivo imaging and therapy studies, and
4) conduct clinical studies using next generation radiopharmaceutical imaging and therapeutic agents.
Education & Training
- Memorial Sloan Kettering Cancer CenterResidency, Radiation Oncology, 2013 - 2017
- Weill Cornell MedicineClass of 2012
Certifications & Licensure
- NY State Medical License 2013 - 2025
- American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- Generation of Site-Specifically Labeled Affinity Reagents via Use of a Self-Labeling Single Domain Antibody.Stanley Fayn, Swarnali Roy, Chino C Cabalteja, Woonghee Lee, Hima Makala
Advanced Science. 2025-02-18 - Evaluation of VLA-4 (integrin α4β1) as a shared target for radiopharmaceutical therapy across solid tumors.Jeyshka M Reyes-González, Harikrishnan Rajkumar, Woonghee Lee, Kwamena E Baidoo, Robert S Edinger
Molecular Cancer Therapeutics. 2025-02-06 - Meta-analysis of randomized controlled trials of external-beam radiation versus transarterial chemoembolization for hepatocellular carcinoma.Ryan A Kuehnle, Leila T Tchelebi, Ethan B Ludmir, Freddy E Escorcia, Sabi Shrestha
Cancer. 2025-02-01
External Links
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: